NO922961L - Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav - Google Patents

Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav

Info

Publication number
NO922961L
NO922961L NO92922961A NO922961A NO922961L NO 922961 L NO922961 L NO 922961L NO 92922961 A NO92922961 A NO 92922961A NO 922961 A NO922961 A NO 922961A NO 922961 L NO922961 L NO 922961L
Authority
NO
Norway
Prior art keywords
solutions
parts
procedures
preparing
pharmaceutical composition
Prior art date
Application number
NO92922961A
Other languages
English (en)
Norwegian (no)
Other versions
NO922961D0 (no
Inventor
Erno Orban
Laszlone Tomori
Maria Kuthy
Tibor Balogh
Laszlo Jaszlits
Imre Moravcsik
Istvan Kovacs
Istvanne Jusztin
Sandor Jancso
Erzsebet Takacs
Tamasne Kiss
Antalne Kovacs
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NO922961D0 publication Critical patent/NO922961D0/no
Publication of NO922961L publication Critical patent/NO922961L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92922961A 1990-11-27 1992-07-27 Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav NO922961L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU907653A HU208491B (en) 1990-11-27 1990-11-27 Process for producing oral pharmaceutical composition containing cyclosporin
PCT/HU1991/000050 WO1992009299A1 (en) 1990-11-27 1991-11-27 Oral pharmaceutical composition containing cyclosporin and process for preparing same

Publications (2)

Publication Number Publication Date
NO922961D0 NO922961D0 (no) 1992-07-27
NO922961L true NO922961L (no) 1992-09-23

Family

ID=10972318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922961A NO922961L (no) 1990-11-27 1992-07-27 Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav

Country Status (18)

Country Link
US (1) US5430017A (cs)
EP (1) EP0512109B1 (cs)
JP (1) JPH082795B2 (cs)
AT (1) ATE129898T1 (cs)
AU (1) AU651154B2 (cs)
CA (1) CA2072983A1 (cs)
CS (1) CS230492A3 (cs)
DE (1) DE69114476T2 (cs)
DK (1) DK0512109T3 (cs)
FI (1) FI923385A0 (cs)
HU (1) HU208491B (cs)
IL (1) IL100162A (cs)
MX (1) MX9102243A (cs)
NO (1) NO922961L (cs)
NZ (1) NZ240762A (cs)
PT (1) PT99623A (cs)
WO (1) WO1992009299A1 (cs)
ZA (1) ZA919352B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
ES2177652T3 (es) 1994-11-03 2002-12-16 Novartis Ag Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
AU764599B2 (en) * 1995-08-25 2003-08-21 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
MX9702809A (es) * 1995-08-25 1998-02-28 Sangstat Medical Corp Formulaciones orales de ciclosporina.
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
KR20050084502A (ko) 1997-01-30 2005-08-26 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
KR100966245B1 (ko) * 1997-03-12 2010-06-28 아보트 러보러터리즈 사이클로스포린 투여용 친수성 2원 시스템
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
DK1154759T3 (da) 1998-12-30 2008-12-08 Dexcel Ltd Dispergerbart koncentrat til indgift af cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE290460C (cs) *
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine

Also Published As

Publication number Publication date
EP0512109B1 (en) 1995-11-08
FI923385A7 (fi) 1992-07-27
US5430017A (en) 1995-07-04
JPH082795B2 (ja) 1996-01-17
IL100162A (en) 1995-11-27
AU8944091A (en) 1992-06-25
FI923385L (fi) 1992-07-27
DK0512109T3 (da) 1995-12-11
WO1992009299A1 (en) 1992-06-11
CA2072983A1 (en) 1992-05-28
JPH05503306A (ja) 1993-06-03
AU651154B2 (en) 1994-07-14
HU208491B (en) 1993-11-29
ATE129898T1 (de) 1995-11-15
PT99623A (pt) 1992-12-31
EP0512109A1 (en) 1992-11-11
CS230492A3 (en) 1992-12-16
HUT60929A (en) 1992-11-30
NZ240762A (en) 1993-05-26
NO922961D0 (no) 1992-07-27
ZA919352B (en) 1992-09-30
HU907653D0 (en) 1991-06-28
DE69114476D1 (de) 1995-12-14
DE69114476T2 (de) 1996-04-18
IL100162A0 (en) 1992-08-18
FI923385A0 (fi) 1992-07-27
MX9102243A (es) 1992-07-08

Similar Documents

Publication Publication Date Title
MX9102243A (es) Composicion farmaceutica oral que contiene ciclosporina y un proceso para prepararse
AU637110B2 (en) Process for reducing the crystal size of ondanestron hydrochloride dihydrate
NO961136L (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
EP0368388A3 (en) 3-Piperidinyl-1,2-benzisoxazoles
ES2002140A6 (es) Procedimiento para producir preparados de derivados de acido arilpropionico resorbibles por via transdermal y acuosos
ATE1288T1 (de) Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel.
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
DK92781A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
ES2155535T3 (es) Inhibidores de sintesis de apoliproteina b.
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
DK0614362T5 (da) Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
IE43693L (en) Androstane derivatives
DE202016008851U1 (de) Gebrauchsfertige Bortezomib-Lösung
ATE35812T1 (de) Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen.
WO2024192323A3 (en) Ophthalmic cream formulations and their uses
EP1132383A4 (en) NEW AGAROFURAN DERIVATIVES, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS MEDICINE
HUP9802096A2 (hu) Piperidino-alkanol-vegyületeket tartalmazó orális adagolású oldat formájú gyógyszerkészítmény, és eljárás előállítására
JPS5750914A (en) Betamethasone external pharmaceutical
US4406888A (en) Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
AU556962B2 (en) Pyridobenzodiazepinone derivatives
KR920021558A (ko) 부분입체이성질체적으로 순수한 1-(2,2-디메틸프로피오닐옥시)-에틸-3-세펨-4-카복실레이트의 결정성 산부가염
RU94032143A (ru) Композиция, содержащая препарат коагуляционного фактора viii, способ ее получения и применение поверхностно-активного вещества в качестве стабилизатора